3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Recruiting
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
1477
Neoplasms
999
Colorectal Neoplasms
832
Carcinoma, Non-Small-Cell Lung
724
Carcinoma, Hepatocellular
683
Stomach Neoplasms
648
Lung Neoplasms
584
Prostatic Neoplasms
543
Pancreatic Neoplasms
456
Rectal Neoplasms
339
Uterine Cervical Neoplasms
303
Colonic Neoplasms
295
Neoplasm Metastasis
294
Ovarian Neoplasms
285
Esophageal Neoplasms
279
Recurrence
278
Leukemia, Myeloid, Acute
253
Head and Neck Neoplasms
241
Multiple Myeloma
232
Brain Neoplasms
204
Polycystic Ovary Syndrome
200
Nasopharyngeal Carcinoma
198
Melanoma
198
Precursor Cell Lymphoblastic Leukemia-Lymphoma
195
Urinary Bladder Neoplasms
193
Lymphoma
178
Liver Neoplasms
178
Endometrial Neoplasms
159
Motor Activity
147
Lymphoma, Large B-Cell, Diffuse
141
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
OTHER
×
Metastatic Pancreatic Adenocarcinoma
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled